Magnolia Medical Technologies
Steripath Micro - Initial Specimen Diversion Device
With Steripath Micro, you can consistently divert and sequester the skin contaminants known to cause false-positive blood culture results. The latest, low-volume Initial Specimen Diversion Device provides you with a reliable contamination-reducing technology for better patient outcomes and decreased cost burdens from a sepsis misdiagnosis.
Most popular related searches
- Designed in collaboration with children’s hospitals nationwide
- FDA-cleared and indicated to reduce blood culture contamination.4
- Requires less than 1mL of blood for patients with limited volumes or difficult intravenous access
- Fast, easy, user-controlled draws with preassembled integrated syringe configurations